Results for tag: "Lidoflazine"

Lidoflazine is a cardiovascular drug used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. It is a calcium channel blocker, meaning it works by blocking the flow of calcium into the cells of the heart and blood vessels, allowing them to relax and widen. This increases the flow of oxygen-rich blood to the heart, reducing the symptoms of angina. Lidoflazine is available in tablet form and is usually taken twice a day. The lidoflazine market is a niche market, with few competitors. It is mainly used in the treatment of angina pectoris, and is not widely used for other cardiovascular conditions. The drug is mainly prescribed in Europe, where it is approved for use in several countries. Some companies in the lidoflazine market include Sanofi, Pfizer, and Novartis. Show Less Read more